Perspectives of Patients With Cancer on the Quality-Adjusted Life Year as a Measure of Value in Healthcare
Autor: | Ellyn Charap, Joanne S. Buzaglo, Alexandra K Zaleta, Linda House, Helen M. Nichols, Elizabeth F. Franklin |
---|---|
Rok vydání: | 2019 |
Předmět: |
Adult
Male Value (ethics) Health Knowledge Attitudes Practice medicine.medical_specialty Adolescent Patients Cost-Benefit Analysis media_common.quotation_subject Young Adult 03 medical and health sciences Survey methodology 0302 clinical medicine Neoplasms Health care medicine Humans 030212 general & internal medicine Aged Quality Indicators Health Care media_common business.industry 030503 health policy & services Health Policy Public Health Environmental and Occupational Health Cancer Health Care Costs Awareness Middle Aged Quarter (United States coin) medicine.disease Quality-adjusted life year Cross-Sectional Studies Treatment Outcome Family medicine Quality of Life Female Quality-Adjusted Life Years Health Expenditures Comprehension 0305 other medical science business Patient awareness Autonomy |
Zdroj: | Value in Health. 22:474-481 |
ISSN: | 1098-3015 |
Popis: | Objectives Healthcare expenditures in the United States continue to grow; to control costs, there has been a shift away from volume-focused care to value-based care. The incorporation of patient perspectives in the development of value-based healthcare is critical, yet research addressing this issue is limited. This study explores awareness and understanding of patients with cancer about the quality-adjusted life year (QALY), as well as their perspectives regarding the use of the QALY to measure value in healthcare. Methods This cross-sectional study used survey methodology to explore patient awareness, understanding, and perspectives on the QALY. A total of 774 patients with cancer and survivors completed this survey in June and July of 2017. Quantitative and qualitative analyses were conducted. Results Results showed that there is limited awareness of the QALY among patients with cancer and survivors and minimal understanding of how the QALY is used. Only one quarter of respondents believed that the QALY was a good way to measure value in healthcare. Some participants (5%) stated that the QALY could be personally helpful to them in their own decision making, indicating the possible usefulness of the QALY as a decision aid in cancer care. Nevertheless, participants expressed concern about other decision makers using the QALY to allocate cancer care and resources and maintained a strong desire for autonomy over personal healthcare choices. Conclusions Although participants believed that the QALY could help them make more informed decisions, there was concern about how it would be used by payers, policymakers, and other decision makers in determining access to care. Implications for policy and research are discussed. |
Databáze: | OpenAIRE |
Externí odkaz: |